Anti-ICAM-1 antisense oligonucleotide has beneficial effects in hepatic ischemia/reperfusion injury May 18, 2000
Anti-HCV ribozyme well tolerated in volunteers; studies in chronically infected patients begin May 12, 2000
RSS